University of California San Francisco

Publications

  1. Prognostic impact of a large mesenteric mass >2 cm in ileal neuroendocrine tumors.
    Kasai Y, Mahuron K, Hirose K, Corvera CU, Kim GE, Hope TA, Shih BE, Warren RS, Bergsland EK, Nakakura EK
    J Surg Oncol. 2019 Dec; 120(8):1311-1317.; 
    PubMed
  2. Safety, tumor trafficking and immunogenicity of chimeric antigen receptor (CAR)-T cells specific for TAG-72 in colorectal cancer.
    Hege KM, Bergsland EK, Fisher GA, Nemunaitis JJ, Warren RS, McArthur JG, Lin AA, Schlom J, June CH, Sherwin SA
    J Immunother Cancer. 2017; 5:22.; 
    PubMed
  3. Wild type p53 transcriptionally represses the SALL2 transcription factor under genotoxic stress.
    Farkas C, Martins CP, Escobar D, Hepp MI, Castro AF, Evan G, Gutiérrez JL, Warren R, Donner DB, Pincheira R
    PLoS One. 2013; 8(9):e73817.; 
    PubMed
  4. Is there currently an established role for the use of predictive or prognostic molecular markers in the management of colorectal cancer? A point/counterpoint.
    Venook AP, Bendell JC, Warren RS
    Am Soc Clin Oncol Educ Book. 2012; 193-200.; 
    PubMed
  5. p27Kip1 in stage III colon cancer: implications for outcome following adjuvant chemotherapy in cancer and leukemia group B protocol 89803.
    Bertagnolli MM, Warren RS, Niedzwiecki D, Mueller E, Compton CC, Redston M, Hall M, Hahn HP, Jewell SD, Mayer RJ, Goldberg RM, Saltz LB, Loda M
    Clin Cancer Res. 2009 Mar 15; 15(6):2116-22.; 
    PubMed
  6. Palliative care for patients with advanced pancreatic and biliary cancers.
    Nakakura EK, Warren RS
    Surg Oncol. 2007 Dec; 16(4):293-7.; 
    PubMed
  7. Liver-directed therapies in colorectal cancer.
    Ruan DT, Warren RS
    Semin Oncol. 2005 Feb; 32(1):85-94.; 
    PubMed
  8. Detection of hepatic metastases from cancers of the gastrointestinal tract by using noninvasive imaging methods (US, CT, MR imaging, PET): a meta-analysis.
    Kinkel K, Lu Y, Both M, Warren RS, Thoeni RF
    Radiology. 2002 Sep; 224(3):748-56.; 
    PubMed
  9. Digitoxin metabolism by rat liver microsomes.
    Schmoldt A, Benthe HF, Haberland G
    Biochem Pharmacol. 1975 Sep 01; 24(17):1639-41.; 
    PubMed
  10. STAT3 regulates inflammatory cytokine production downstream of TNFR1 by inducing expression of TNFAIP3/A20.
    Antonia RJ, Karelehto E, Toriguchi K, Matli M, Warren RS, Pfeffer LM, Donner DB
    J Cell Mol Med. 2022 08; 26(16):4591-4601.; 
    PubMed
  11. RasGRP1 is a potential biomarker to stratify anti-EGFR therapy response in colorectal cancer.
    Gbenedio OM, Bonnans C, Grun D, Wang CY, Hatch AJ, Mahoney MR, Barras D, Matli M, Miao Y, Garcia KC, Tejpar S, Delorenzi M, Venook AP, Nixon AB, Warren RS, Roose JP, Depeille P
    JCI Insight. 2019 06 25; 5.; 
    PubMed
  12. Association Between Results of a Gene Expression Signature Assay and Recurrence-Free Interval in Patients With Stage II Colon Cancer in Cancer and Leukemia Group B 9581 (Alliance).
    Niedzwiecki D, Frankel WL, Venook AP, Ye X, Friedman PN, Goldberg RM, Mayer RJ, Colacchio TA, Mulligan JM, Davison TS, O'Brien E, Kerr P, Johnston PG, Kennedy RD, Harkin DP, Schilsky RL, Bertagnolli MM, Warren RS, Innocenti F
    J Clin Oncol. 2016 09 01; 34(25):3047-53.; 
    PubMed
  13. Incomplete inhibition of phosphorylation of 4E-BP1 as a mechanism of primary resistance to ATP-competitive mTOR inhibitors.
    Ducker GS, Atreya CE, Simko JP, Hom YK, Matli MR, Benes CH, Hann B, Nakakura EK, Bergsland EK, Donner DB, Settleman J, Shokat KM, Warren RS
    Oncogene. 2014 Mar 20; 33(12):1590-600.; 
    PubMed
  14. Microsatellite instability and loss of heterozygosity at chromosomal location 18q: prospective evaluation of biomarkers for stages II and III colon cancer--a study of CALGB 9581 and 89803.
    Bertagnolli MM, Redston M, Compton CC, Niedzwiecki D, Mayer RJ, Goldberg RM, Colacchio TA, Saltz LB, Warren RS
    J Clin Oncol. 2011 Aug 10; 29(23):3153-62.; 
    PubMed
  15. Homeodomain transcription factor NKX2.2 functions in immature cells to control enteroendocrine differentiation and is expressed in gastrointestinal neuroendocrine tumors.
    Wang YC, Gallego-Arteche E, Iezza G, Yuan X, Matli MR, Choo SP, Zuraek MB, Gogia R, Lynn FC, German MS, Bergsland EK, Donner DB, Warren RS, Nakakura EK
    Endocr Relat Cancer. 2009 Mar; 16(1):267-79.; 
    PubMed
  16. Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer: a randomized trial of efficacy, quality of life, and molecular markers (CALGB 9481).
    Kemeny NE, Niedzwiecki D, Hollis DR, Lenz HJ, Warren RS, Naughton MJ, Weeks JC, Sigurdson ER, Herndon JE, Zhang C, Mayer RJ
    J Clin Oncol. 2006 Mar 20; 24(9):1395-403.; 
    PubMed
  17. Aggressive surgery for metastatic liver neuroendocrine tumors.
    Norton JA, Warren RS, Kelly MG, Zuraek MB, Jensen RT
    Surgery. 2003 Dec; 134(6):1057-63; discussion 1063-5.; 
    PubMed
  18. Quantitative fractionation of alkaline phosphatase isoenzymes according to their thermostability.
    PetitClerc C
    Clin Chem. 1976 Jan; 22(1):42-8.; 
    PubMed
  19. A novel stratification of mesenteric mass involvement as a predictor of challenging mesenteric lymph node dissection by minimally invasive approach for ileal neuroendocrine tumors.
    Kasai Y, Mahuron K, Hirose K, Corvera CU, Kim GE, Hope TA, Shih BE, Warren RS, Bergsland EK, Nakakura EK
    J Surg Oncol. 2020 Aug; 122(2):204-211.; 
    PubMed
  20. Discontinuities in soil strength contribute to destabilization of nutrient-enriched creeks.
    Wigand C, Watson EB, Martin R, Johnson DS, Warren RS, Hanson A, Davey E, Johnson R, Deegan L
    Ecosphere. 2018 Aug; 9(8):e02329.; 
    PubMed
  21. CpG island methylator phenotype is associated with response to adjuvant irinotecan-based therapy for stage III colon cancer.
    Shiovitz S, Bertagnolli MM, Renfro LA, Nam E, Foster NR, Dzieciatkowski S, Luo Y, Lao VV, Monnat RJ, Emond MJ, Maizels N, Niedzwiecki D, Goldberg RM, Saltz LB, Venook A, Warren RS, Grady WM, Alliance for Clinical Trials in Oncology
    Gastroenterology. 2014 Sep; 147(3):637-45.; 
    PubMed
  22. Lymph node sampling rates and predictors of nodal metastasis in pancreatic neuroendocrine tumor resections: the UCSF experience with 149 patients.
    Parekh JR, Wang SC, Bergsland EK, Venook AP, Warren RS, Kim GE, Nakakura EK
    Pancreas. 2012 Aug; 41(6):840-4.; 
    PubMed
  23. Identification of unknown primary tumors in patients with neuroendocrine liver metastases.
    Wang SC, Parekh JR, Zuraek MB, Venook AP, Bergsland EK, Warren RS, Nakakura EK
    Arch Surg. 2010 Mar; 145(3):276-80.; 
    PubMed
  24. Prognostic importance of superior diaphragmatic adenopathy at computed tomography in patients with resectable hepatic metastases from colorectal carcinoma.
    Aslam R, Coakley FV, Williams G, Yeh BM, Joe BN, Zuraek MB, Warren RS
    J Comput Assist Tomogr. 2008 Mar-Apr; 32(2):173-7.; 
    PubMed
  25. Hypoxia-induced radioresistance is independent of hypoxia-inducible factor-1A in vitro.
    Arvold ND, Guha N, Wang D, Matli M, Deen DF, Warren RS, Haas-Kogan DA
    Int J Radiat Oncol Biol Phys. 2005 May 01; 62(1):207-12.; 
    PubMed
  26. Isolation, sequencing, and expression of a cDNA for the HXM-A form of xenobiotic/medium-chain fatty acid:CoA ligase from human liver mitochondria.
    Vessey DA, Lau E, Kelley M, Warren RS
    J Biochem Mol Toxicol. 2003; 17(1):1-6.; 
    PubMed
  27. Analyses of rumen fluid from "sudden death", lactic acidotic and healthy cattle fed high concentrate ration.
    Wilson JR, Bartley EE, Anthony HD, Brent BE, Sapienza DA, Chapman TE, Dayton AD, Milleret RJ, Frey RA, Meyer RM
    J Anim Sci. 1975 Nov; 41(5):1249-55.; 
    PubMed
  28. Relative contribution of clinicopathological variables, genomic markers, transcriptomic subtyping and microenvironment features for outcome prediction in stage II/III colorectal cancer.
    Dienstmann R, Villacampa G, Sveen A, Mason MJ, Niedzwiecki D, Nesbakken A, Moreno V, Warren RS, Lothe RA, Guinney J
    Ann Oncol. 2019 10 01; 30(10):1622-1629.; 
    PubMed
  29. Reply to L. Casadaban et al.
    Niedzwiecki D, Frankel WL, Venook AP, Ye X, Friedman PN, Goldberg RM, Mayer RJ, Colacchio TA, Mulligan JM, Davison TS, O'Brien E, Kerr P, Johnston PG, Kennedy RD, Harkin DP, Schilsky RL, Bertagnolli MM, Warren RS, Innocenti F
    J Clin Oncol. 2017 04 20; 35(12):1373-1374.; 
    PubMed
  30. Association of TP53 mutational status and gender with survival after adjuvant treatment for stage III colon cancer: results of CALGB 89803.
    Warren RS, Atreya CE, Niedzwiecki D, Weinberg VK, Donner DB, Mayer RJ, Goldberg RM, Compton CC, Zuraek MB, Ye C, Saltz LB, Bertagnolli MM
    Clin Cancer Res. 2013 Oct 15; 19(20):5777-87.; 
    PubMed
  31. Complete and safe resection of challenging retroperitoneal tumors: anticipation of multi-organ and major vascular resection and use of adjunct procedures.
    Tseng WW, Wang SC, Eichler CM, Warren RS, Nakakura EK
    World J Surg Oncol. 2011 Nov 04; 9:143.; 
    PubMed
  32. Microsatellite instability predicts improved response to adjuvant therapy with irinotecan, fluorouracil, and leucovorin in stage III colon cancer: Cancer and Leukemia Group B Protocol 89803.
    Bertagnolli MM, Niedzwiecki D, Compton CC, Hahn HP, Hall M, Damas B, Jewell SD, Mayer RJ, Goldberg RM, Saltz LB, Warren RS, Redston M
    J Clin Oncol. 2009 Apr 10; 27(11):1814-21.; 
    PubMed
  33. Nutlin3 blocks vascular endothelial growth factor induction by preventing the interaction between hypoxia inducible factor 1alpha and Hdm2.
    LaRusch GA, Jackson MW, Dunbar JD, Warren RS, Donner DB, Mayo LD
    Cancer Res. 2007 Jan 15; 67(2):450-4.; 
    PubMed
  34. Palliative techniques for hepatic cancer.
    Ruan DT, Warren RS
    Surg Oncol Clin N Am. 2004 Jul; 13(3):505-16, ix.; 
    PubMed
  35. Liver-directed viral therapy for cancer p53-targeted adenoviruses and beyond.
    Warren RS, Kirn DH
    Surg Oncol Clin N Am. 2002 Jul; 11(3):571-88, vi.; 
    PubMed
  36. Synchronous Versus Metachronous Colorectal Liver Metastasis Yields Similar Survival in Modern Era.
    Wisneski AD, Jin C, Huang CY, Warren R, Hirose K, Nakakura EK, Corvera CU
    J Surg Res. 2020 12; 256:476-485.; 
    PubMed
  37. Mitogen Inducible Gene-6 Is a Prognostic Marker for Patients with Colorectal Liver Metastases.
    Donner DB, Ruan DT, Toriguchi K, Bergsland EK, Nakakura EK, Lin MH, Antonia RJ, Warren RS
    Transl Oncol. 2019 Mar; 12(3):550-560.; 
    PubMed
  38. Unexpected insights for anti-EGFR cancer therapy.
    Depeille P, Warren RS, Roose JP
    Oncotarget. 2015 Aug 07; 6(22):18746-7.; 
    PubMed
  39. Biologic determinants of tumor recurrence in stage II colon cancer: validation study of the 12-gene recurrence score in cancer and leukemia group B (CALGB) 9581.
    Venook AP, Niedzwiecki D, Lopatin M, Ye X, Lee M, Friedman PN, Frankel W, Clark-Langone K, Millward C, Shak S, Goldberg RM, Mahmoud NN, Warren RS, Schilsky RL, Bertagnolli MM
    J Clin Oncol. 2013 May 10; 31(14):1775-81.; 
    PubMed
  40. Pancreatic adenocarcinoma.
    Tempero MA, Arnoletti JP, Behrman S, Ben-Josef E, Benson AB, Berlin JD, Cameron JL, Casper ES, Cohen SJ, Duff M, Ellenhorn JD, Hawkins WG, Hoffman JP, Kuvshinoff BW, Malafa MP, Muscarella P, Nakakura EK, Sasson AR, Thayer SP, Tyler DS, Warren RS, Whiting S, Willett C, Wolff RA, NCCN Pancreatic Adenocarcinoma
    J Natl Compr Canc Netw. 2010 Sep; 8(9):972-1017.; 
    PubMed
  41. Association of family history with cancer recurrence and survival among patients with stage III colon cancer.
    Chan JA, Meyerhardt JA, Niedzwiecki D, Hollis D, Saltz LB, Mayer RJ, Thomas J, Schaefer P, Whittom R, Hantel A, Goldberg RM, Warren RS, Bertagnolli M, Fuchs CS
    JAMA. 2008 Jun 04; 299(21):2515-23.; 
    PubMed
  42. Pancreatic adenocarcinoma: Clinical Practice Guidelines in Oncology.
    Tempero MA, Behrman S, Ben-Josef E, Benson AB, Cameron JL, Casper ES, Hoffman JP, Karl RC, Kim P, Koh WJ, Kuvshinoff BW, Melvin WS, Muscarella P, Sasson AR, Shibata S, Shrieve DC, Talamonti MS, Tyler DS, Vickers SM, Warren RS, Willett C, Wolff RA, National Comprehensive Cancer Network
    J Natl Compr Canc Netw. 2005 Sep; 3(5):598-626.; 
    PubMed
  43. beta-Catenin regulates vascular endothelial growth factor expression in colon cancer.
    Easwaran V, Lee SH, Inge L, Guo L, Goldbeck C, Garrett E, Wiesmann M, Garcia PD, Fuller JH, Chan V, Randazzo F, Gundel R, Warren RS, Escobedo J, Aukerman SL, Taylor RN, Fantl WJ
    Cancer Res. 2003 Jun 15; 63(12):3145-53.; 
    PubMed
  44. Activity and longevity of insect growth regulators against mosquitoes.
    Mulla MS, Darwazeh HA
    J Econ Entomol. 1975 Dec; 68(6):791-4.; 
    PubMed
  45. Residual tumor volume discriminates prognosis after surgery for neuroendocrine liver metastasis.
    Kasai Y, Hirose K, Corvera CU, Kim GE, Hope TA, Shih BE, Harun N, Kim MO, Warren RS, Bergsland EK, Nakakura EK
    J Surg Oncol. 2020 Feb; 121(2):330-336.; 
    PubMed
  46. Sampling strategies to capture single-cell heterogeneity.
    Rajaram S, Heinrich LE, Gordan JD, Avva J, Bonness KM, Witkiewicz AK, Malter JS, Atreya CE, Warren RS, Wu LF, Altschuler SJ
    Nat Methods. 2017 Oct; 14(10):967-970.; 
    PubMed
  47. Prognostic impact of deficient DNA mismatch repair in patients with stage III colon cancer from a randomized trial of FOLFOX-based adjuvant chemotherapy.
    Sinicrope FA, Mahoney MR, Smyrk TC, Thibodeau SN, Warren RS, Bertagnolli MM, Nelson GD, Goldberg RM, Sargent DJ, Alberts SR
    J Clin Oncol. 2013 Oct 10; 31(29):3664-72.; 
    PubMed
  48. Combination of ATP-competitive mammalian target of rapamycin inhibitors with standard chemotherapy for colorectal cancer.
    Atreya CE, Ducker GS, Feldman ME, Bergsland EK, Warren RS, Shokat KM
    Invest New Drugs. 2012 Dec; 30(6):2219-25.; 
    PubMed
  49. The ETS oncogene family transcription factor FEV identifies serotonin-producing cells in normal and neoplastic small intestine.
    Wang YC, Zuraek MB, Kosaka Y, Ota Y, German MS, Deneris ES, Bergsland EK, Donner DB, Warren RS, Nakakura EK
    Endocr Relat Cancer. 2010 Mar; 17(1):283-91.; 
    PubMed
  50. Introduction.
    Warren RS, Nakakura EK
    Surg Oncol. 2007 Dec; 16(4):235.; 
    PubMed
  51. Fractional genomic alteration detected by array-based comparative genomic hybridization independently predicts survival after hepatic resection for metastatic colorectal cancer.
    Mehta KR, Nakao K, Zuraek MB, Ruan DT, Bergsland EK, Venook AP, Moore DH, Tokuyasu TA, Jain AN, Warren RS, Terdiman JP, Waldman FM
    Clin Cancer Res. 2005 Mar 01; 11(5):1791-7.; 
    PubMed
  52. Thorotrast-induced liver neoplasia: a collective review.
    Lipshutz GS, Brennan TV, Warren RS
    J Am Coll Surg. 2002 Nov; 195(5):713-8.; 
    PubMed
  53. Action of propranolol on mitochondrial functions--effects on energized ion fluxes in the presence of valinomycin.
    Järvisalo J, Saris NE
    Biochem Pharmacol. 1975 Sep 15; 24(18):1701-5.; 
    PubMed
  54. Metastatic colorectal adenocarcinoma tumor purity assessment from whole exome sequencing data.
    Tbeileh N, Timmerman L, Mattis AN, Toriguchi K, Kasai Y, Corvera C, Nakakura E, Hirose K, Donner DB, Warren RS, Karelehto E
    PLoS One. 2023; 18(4):e0271354.; 
    PubMed
  55. High thymidylate synthase gene expression predicts poor outcome after resection of hepatocellular carcinoma.
    Donner DB, Nakakura EK, Venook AP, Lenz HJ, Zhang W, Hwang J, Bergsland EK, Lin MH, Toriguchi K, Antonia RJ, Warren RS
    PLoS One. 2019; 14(7):e0219469.; 
    PubMed
  56. A Study of Thymidylate Synthase Expression as a Biomarker for Resectable Colon Cancer: Alliance (Cancer and Leukemia Group B) 9581 and 89803.
    Niedzwiecki D, Hasson RM, Lenz HJ, Ye C, Redston M, Ogino S, Fuchs CS, Compton CC, Mayer RJ, Goldberg RM, Colacchio TA, Saltz LB, Warren RS, Bertagnolli MM
    Oncologist. 2017 01; 22(1):107-114.; 
    PubMed
  57. PTEN expression is consistent in colorectal cancer primaries and metastases and associates with patient survival.
    Atreya CE, Sangale Z, Xu N, Matli MR, Tikishvili E, Welbourn W, Stone S, Shokat KM, Warren RS
    Cancer Med. 2013 Aug; 2(4):496-506.; 
    PubMed
  58. Documenting the natural history of patients with resected stage II adenocarcinoma of the colon after random assignment to adjuvant treatment with edrecolomab or observation: results from CALGB 9581.
    Niedzwiecki D, Bertagnolli MM, Warren RS, Compton CC, Kemeny NE, Benson AB, Eckhardt SG, Alberts S, Porjosh GN, Kerr DJ, Fields A, Rougier P, Pipas JM, Schwartz JH, Atkins J, O'Rourke M, Perry MC, Goldberg RM, Mayer RJ, Colacchio TA
    J Clin Oncol. 2011 Aug 10; 29(23):3146-52.; 
    PubMed
  59. Mitogen-inducible gene-6 expression correlates with survival and is an independent predictor of recurrence in BRAF(V600E) positive papillary thyroid cancers.
    Ruan DT, Warren RS, Moalem J, Chung KW, Griffin AC, Shen W, Duh QY, Nakakura E, Donner DB, Khanafshar E, Weng J, Clark OH, Kebebew E
    Surgery. 2008 Dec; 144(6):908-13; discussion 913-4.; 
    PubMed
  60. Pancreatoblastoma in an adult: case report and review of the literature.
    Rajpal S, Warren RS, Alexander M, Yeh BM, Grenert JP, Hintzen S, Ljung BM, Bergsland EK
    J Gastrointest Surg. 2006 Jun; 10(6):829-36.; 
    PubMed
  61. Characterization of triacsin C inhibition of short-, medium-, and long-chain fatty acid: CoA ligases of human liver.
    Vessey DA, Kelley M, Warren RS
    J Biochem Mol Toxicol. 2004; 18(2):100-6.; 
    PubMed
  62. Expression and endocytosis of VEGF and its receptors in human colonic vascular endothelial cells.
    Wang D, Lehman RE, Donner DB, Matli MR, Warren RS, Welton ML
    Am J Physiol Gastrointest Liver Physiol. 2002 Jun; 282(6):G1088-96.; 
    PubMed
  63. RBMS1 Suppresses Colon Cancer Metastasis through Targeted Stabilization of Its mRNA Regulon.
    Yu J, Navickas A, Asgharian H, Culbertson B, Fish L, Garcia K, Olegario JP, Dermit M, Dodel M, Hänisch B, Luo Y, Weinberg EM, Dienstmann R, Warren RS, Mardakheh FK, Goodarzi H
    Cancer Discov. 2020 09; 10(9):1410-1423.; 
    PubMed
  64. A Patient-derived Xenograft Model of Pancreatic Neuroendocrine Tumors Identifies Sapanisertib as a Possible New Treatment for Everolimus-resistant Tumors.
    Chamberlain CE, German MS, Yang K, Wang J, VanBrocklin H, Regan M, Shokat KM, Ducker GS, Kim GE, Hann B, Donner DB, Warren RS, Venook AP, Bergsland EK, Lee D, Wang Y, Nakakura EK
    Mol Cancer Ther. 2018 12; 17(12):2702-2709.; 
    PubMed
  65. RasGRP1 opposes proliferative EGFR-SOS1-Ras signals and restricts intestinal epithelial cell growth.
    Depeille P, Henricks LM, van de Ven RA, Lemmens E, Wang CY, Matli M, Werb Z, Haigis KM, Donner D, Warren R, Roose JP
    Nat Cell Biol. 2015 Jun; 17(6):804-15.; 
    PubMed
  66. Imaging a functional tumorigenic biomarker in the transformed epithelium.
    LeBeau AM, Lee M, Murphy ST, Hann BC, Warren RS, Delos Santos R, Kurhanewicz J, Hanash SM, VanBrocklin HF, Craik CS
    Proc Natl Acad Sci U S A. 2013 Jan 02; 110(1):93-8.; 
    PubMed
  67. Lack of NKX2.2 expression in bronchopulmonary typical carcinoid tumors: implications for patients with neuroendocrine tumor metastases and unknown primary site.
    Wang YC, Iezza G, Zuraek MB, Jablons DM, Theodore PR, Bergsland EK, Donner DB, Warren RS, Nakakura EK
    J Surg Res. 2010 Sep; 163(1):47-51.; 
    PubMed
  68. Compound muscle action potentials and spontaneous electromyography can be used to identify and protect the femoral nerve during resection of large retroperitoneal tumors.
    Guo L, Clark JP, Warren RS, Nakakura EK
    Ann Surg Oncol. 2008 Jun; 15(6):1594-9.; 
    PubMed
  69. [Liver metastases from colorectal cancer. Is the practice of surgery based on the best clinical evidence possible?].
    Durán Giménez-Rico H, García-Aguilar J, Warren RS, Iborra P, Guerrero V
    Cir Esp. 2005 Aug; 78(2):75-85.; 
    PubMed
  70. Distinguishing features of self-limiting adult small-bowel intussusception identified at CT.
    Lvoff N, Breiman RS, Coakley FV, Lu Y, Warren RS
    Radiology. 2003 Apr; 227(1):68-72.; 
    PubMed
  71. A double-blind controlled therapeutic trial of lorazepam vs medazepam in psychosomatic conditions in general practice.
    Sim M, Bindman E, Morrison I, Sandilands D
    Br J Clin Pract. 1975 Nov; 29(11):304-6.; 
    PubMed